Curt Oltmans
Chief Legal Officer & Corporate Secretary Fulcrum Therapeutics
Seminars
Wednesday 5th August 2026
Panel Discussion: Stabilizing Development Momentum to Preserve Market Confidence During Regulatory Volatility
9:15 am
- Maintain investor and partner confidence by aligning regulatory pivots with disciplined communications
- Protect timelines and budgets by responding decisively to CRLs, endpoint shifts, and evolving agency expectations
- Strengthen resilience by leveraging patient advocacy, public affairs, and cross-functional escalation pathways during periods of agency uncertainty
Wednesday 5th August 2026
Fireside Chat: Positioning Assets Strategically to Protect Valuation Amid Pricing Reform & Federal Policy Shifts
11:15 am
- Safeguard enterprise value by understanding how IRA, potential MFN expansion, and federal reform influence asset modeling, even pre-approval
- Strengthen board-level conversations by framing pricing reform as a strategic scenario, not a technical reimbursement issue
- Prevent future revenue compression by integrating pricing policy awareness into indication sequencing and lifecycle planning early
